OrsoBio has announced the publication in Nature Medicine of Phase I clinical trial data for TLC-2716, an oral liver-targeted ...
GlobalData on MSN
Speech biomarkers offer new lease of life to patient experience and trial retention
According to Adalyon’s CEO, Ulrik Zeuthen, speech-based biomarkers can be used across several applications to optimise trial ...
A study using agentic artificial intelligence to detect early signs of cognitive decline in unstructured m | Mass General ...
Explore the unique mechanisms of bispecific antibodies and their rapid availability compared to CAR T-cell therapies in cancer treatment.
As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...
New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures PHILADELPHIA, Jan. 6, 2026 /PRNewswire/ -- ...
New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial ...
A large-scale clinical trial has determined that a specific brain stimulation device, previously cleared by regulators for ...
SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at ...
BioNTech will present significant clinical trial data at the prestigious ASCO Annual Meeting, highlighting the advancement of its diversified oncology portfolio. The preliminary results for BNT327 and ...
Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies ...
Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback